A Rare Presentation of Drug-Induced Autoimmune Hepatitis and the Role of Male Enhancement Supplements
Juan Enciso, Ruhi Vasavada-Patel, Kyle Lien

TL;DR
A man developed autoimmune liver disease after using a male enhancement supplement, suggesting it may trigger drug-induced autoimmune hepatitis.
Contribution
Highlights a rare case linking male enhancement supplements to drug-induced autoimmune hepatitis.
Findings
A 45-year-old male developed autoimmune hepatitis after using a male enhancement supplement.
The case suggests that over-the-counter supplements may act as environmental triggers for autoimmune liver disease.
Abstract
Autoimmune hepatitis (AIH) is a condition characterized by an autoimmune response resulting in chronic inflammatory liver disease. Its presentation is marked by significant increases in serum immunoglobulins and the production of active autoantibodies that target liver tissue. AIH is often associated with other autoimmune disorders, which can lead to overlapping clinical syndromes. However, alternative theories propose that exposure to specific environmental triggers can initiate this autoimmune cascade. We present the case of a 45-year-old male who sought evaluation for abdominal discomfort and was subsequently diagnosed with drug-induced AIH (DIAIH) following prolonged use of an over-the-counter male-enhancing supplement.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLiver Diseases and Immunity · Liver Disease Diagnosis and Treatment · Drug-Induced Hepatotoxicity and Protection
